Abera Bioscience
8.15
SEK
-7.39 %
Less than 1K followers
ABERA
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Ownership
Investor consensus
Abera Bioscience is active in biotechnology. The company specializes in the development of vaccines based on its own internal developed and patented platform. The technology is mainly used in the development of new vaccines where the focus is on the main areas of pneumococci and oncology. The business is located around the Nordic market. The company was founded in 2012 and is headquartered in Solna.
Read moreMarket cap
125.12M SEK
Turnover
37.72K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Financial calendar
21/8
2025
Interim report Q2'25
13/11
2025
Interim report Q3'25
12/2
2026
Annual report '25
All
Press releases
ShowingAll content types
Abera Bioscience visar på ny styrka i vaccinplattformen - långtidslagring möjliggör snabbare och kostnadseffektiv pandemiberedskap
Abera Bioscience: Artikel: Mukosala vacciner
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools